adenoviru
infect
tremend
impact
cellular
silenc
machineri
adenovirus
express
high
amount
noncod
viru
associ
va
rna
abl
satur
key
factor
rna
interfer
rnai
process
pathway
exportin
dicer
furthermor
proport
va
rna
cleav
dicer
viral
microrna
mivarna
satur
argonaut
essenti
protein
mirna
function
thu
process
function
cellular
mirna
block
adenoviralinfect
cell
howev
viral
mirna
activ
target
express
cellular
gene
involv
relev
function
cell
prolifer
dna
repair
rna
regul
interestingli
cellular
silenc
machineri
activ
earli
time
postinfect
use
control
adenoviru
cell
cycl
relev
therapeut
purpos
adenovir
infect
recombin
adenovirus
use
vector
gene
therapi
manipul
viral
genom
allow
use
adenovir
vector
express
therapeut
mirna
silenc
rnai
machineri
lead
safer
vector
specif
tropism
articl
part
special
issu
entitl
microrna
viral
gene
regul
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
ev
e
r
c
l
c
e
b
b
g
r
rna
interfer
rnai
posttranscript
mechan
gene
silenc
highli
conserv
eukaryot
rnai
control
gene
express
interact
complementari
sequenc
target
mrna
singl
strand
molecul
rna
small
interfer
sirna
microrna
mirna
sirna
bind
target
mrna
perfect
complementar
instead
mirna
show
partial
match
gener
target
mrna
interact
small
rna
target
result
gene
silenc
sirna
mirna
bound
rnainduc
silenc
complex
risc
thu
risc
guid
target
mrna
small
rna
bind
target
perfect
complementar
induc
riscmedi
cleavag
target
rna
mirna
guid
risc
induc
gene
silenc
yet
fulli
understood
mechan
lead
translat
repress
deadenyl
degrad
mrna
target
mirna
precursor
transcrib
rna
polymeras
ii
long
primari
transcript
name
primirna
primirna
contain
one
immatur
mirna
primirna
process
nuclear
rnase
iii
call
drosha
gener
imperfectli
pair
stemloop
molecul
approxim
nucleotid
known
premirna
premirna
transfer
cytosol
exportin
anoth
rnase
iii
dicer
gener
matur
doublestrand
mirna
approxim
nucleotid
follow
dicer
cleavag
result
rna
duplex
load
risc
argonaut
ago
one
protein
complex
separ
two
strand
doublestrand
rna
guid
strand
remain
risc
matur
mirna
wherea
strand
passeng
strand
degrad
riscmirna
complex
prepar
regul
target
mrna
mirna
regul
gene
express
contribut
essenti
process
differenti
apoptosi
prolifer
express
level
one
combin
sever
mirna
induc
serv
signatur
specif
medic
condit
cancer
obes
diabet
neurodegen
diseas
cellular
signal
cellular
stress
upregul
downregul
express
sever
mirna
trigger
new
cell
behaviour
alter
cellular
mirna
content
seem
particularli
evid
cell
infect
viru
review
recent
viral
infect
alter
mirna
profil
infect
cell
sever
mean
infect
per
se
chang
express
level
sever
cellular
mirna
may
induc
viru
may
result
cellular
respons
viral
infect
furthermor
sever
virus
shown
express
viral
mirna
control
level
viral
protein
decreas
express
cellular
factor
antivir
properti
virus
studi
detail
understand
impact
mirna
express
function
focu
adenovirus
serv
good
exampl
demonstr
varieti
strategi
may
use
viru
alter
mirna
machineri
express
cellular
mirna
alter
upon
adenovir
infect
moreov
adenovirus
express
sever
viral
mirna
final
viru
block
key
player
silenc
machineri
result
inhibit
cellular
mirna
process
function
adenovirus
studi
year
investig
viral
function
contribut
understand
import
aspect
cellular
physiolog
addit
recombin
version
adenoviru
extens
use
vector
gene
therapi
fact
agent
frequent
use
viral
vector
clinic
trial
icosahedr
capsid
protrud
fiber
protein
store
linear
doublestrand
genom
adenoviru
adenovir
genom
approxim
kilobas
contain
earli
late
gene
invert
termin
repeat
end
fig
fibermedi
bind
cell
surfac
start
viral
infect
divid
earli
late
phase
earli
phase
viral
infect
viral
genom
reach
nucleu
host
cell
earli
viral
gene
transcrib
translat
function
earli
protein
devot
block
host
antivir
respons
apoptosi
activ
cellcycl
facilit
viral
replic
induc
express
late
viral
gene
protein
first
express
upon
viral
infect
execut
sever
task
activ
transcript
block
retinoblastoma
rb
lead
activ
target
gene
caus
uncontrol
growth
howev
shown
oncogen
tumorsuppress
properti
cell
express
balanc
two
activ
could
regul
properti
cellular
transform
could
benefici
viral
cell
cycl
sinc
adenoviru
infect
mainli
differenti
nondivid
epitheli
tissu
promot
cell
prolifer
could
help
epithelialtomesenchym
cell
transform
viral
dna
replic
tumorsuppress
properti
could
promot
mesenchymaltoepitheli
transform
therebi
provid
cellular
environ
could
facilit
step
viru
multipl
review
activ
allow
express
earli
viral
gene
requir
replic
viral
genom
replic
express
delay
earli
gene
ix
mark
initi
late
phase
viral
cycl
express
late
transcript
lead
product
capsid
protein
penton
hexon
fiber
factor
requir
viral
packag
releas
protein
total
deriv
singl
premrna
process
altern
splice
differ
mrna
fact
process
viral
premrna
earli
late
phase
requir
proper
altern
splice
polyadenyl
furthermor
altern
splice
premrna
differ
throughout
viral
cycl
fig
instanc
premrna
preferenti
splice
mrna
earli
phase
contrast
mrna
late
phase
differ
altern
splice
also
observ
initi
versu
end
late
phase
sever
viral
cellular
factor
involv
regul
altern
splice
adenovir
premrna
welldescrib
exampl
cellular
protein
whose
inactiv
dephosphoryl
lead
differ
altern
splice
result
product
viral
iiia
protein
earli
late
time
point
respect
cellular
splice
factor
modifi
viral
infect
adequ
altern
splice
viral
transcript
occur
howev
chang
neg
impact
altern
splice
cellular
premrna
fact
sever
cellular
pathway
affect
adenoviru
cellcycl
dna
repair
enzym
inactiv
avoid
concatemer
adenovir
genom
interferon
ifn
pathway
block
imped
host
antivir
respons
affect
sever
key
molecul
furthermor
cellular
mrna
transport
cytoplasm
repress
transport
adenovir
rna
cytoplasm
translat
cellular
mrna
also
inhibit
adenovir
mrna
preferenti
translat
final
sever
essenti
protein
rnai
silenc
pathway
block
satur
adenovir
infect
sinc
mammalian
virus
inhibit
hostderiv
sirna
mirna
rnaiblock
strategi
could
enhanc
infect
like
adenoviru
mammalian
virus
evolv
way
block
rnai
pathway
includ
express
protein
primat
foami
ta
hiv
tat
influenza
viru
vaccinia
viru
hcv
core
ebola
viru
htlv
rex
coronaviru
accessori
protein
moreov
certain
viral
rna
also
abil
inhibit
silenc
pathway
good
exampl
tar
rna
express
viru
bind
sequest
hostderiv
tar
rna
bind
protein
trbp
necessari
cofactor
dicer
function
anoth
exampl
adenoviru
virusassoci
va
rna
review
va
rna
short
noncod
rna
transcrib
cellular
rna
polymeras
iii
adenovir
genom
adenoviru
express
one
two
va
rna
vai
found
adenoviru
serotyp
wherea
vaii
detect
length
differ
va
rna
similar
vai
nucleotid
long
vaii
nucleotid
long
nucleotid
sequenc
vai
vaii
rna
particular
viru
significantli
differ
one
anoth
divers
observ
analyz
vai
vaii
among
differ
serotyp
especi
belong
differ
group
f
comparison
adenoviru
serotyp
shown
conserv
region
end
near
terminu
shown
sequenc
requir
va
rna
transcript
initi
termin
besid
homolog
highli
conserv
sequenc
nucleotid
present
throughout
va
gene
seem
requir
mainten
va
rna
secondari
structur
secondari
structur
model
va
rna
base
extens
mutagenesi
structur
probe
studi
togeth
compar
sequenc
analysi
result
analys
clearli
show
va
rna
fold
stemloop
structur
fig
structur
fairli
well
conserv
va
rna
slight
differ
among
differ
group
va
secondari
structur
divid
three
region
termin
stem
includ
pair
end
panhandl
apic
stem
structur
central
domain
domain
associ
function
activ
termin
apic
stem
highli
conserv
structur
mutat
one
strand
stem
compens
complementari
chang
strand
also
case
pair
highli
conserv
basedpair
tetranucleotid
ggguaccc
locat
central
domain
suggest
va
function
nucleotid
sequenc
less
import
specif
structur
howev
sinc
singl
point
mutat
central
domain
reduc
va
activ
specif
sequenc
may
also
role
va
function
recent
describ
vai
apic
stem
adopt
two
differ
conform
differ
function
activ
coexist
infect
cell
studi
regard
va
rna
structur
function
use
human
adenoviru
serotyp
model
inactiv
vai
adenoviru
caus
decreas
viral
growth
va
rna
delet
viral
growth
decreas
delet
vaii
alon
littl
impact
viral
growth
suggest
vaii
might
exert
nonessenti
function
compens
part
lack
vai
vaimut
adenoviru
earli
observ
show
protein
synthesi
decreas
cell
infect
adenoviru
lack
vai
compar
wild
type
adenoviru
suggest
activ
role
vai
promot
translat
effect
associ
phosphoryl
eukaryot
translat
initi
factor
phosphoryl
increas
affin
subunit
prevent
recharg
initi
complex
gtp
result
translat
inhibit
later
protein
kinas
r
pkr
identifi
kinas
respons
phosphoryl
subsequ
arrest
translat
induc
interferon
pkr
serinethreonin
kinas
becom
activ
dsrna
common
intermedi
viral
replic
act
major
compon
cellular
antivir
pathway
inhibit
pkr
vai
elimin
block
translat
machineri
thu
allow
effici
product
viral
protein
previous
describ
va
rna
structur
divid
three
major
domain
apic
stem
central
domain
termin
domain
fig
apic
stemloop
requir
bind
pkr
central
domain
involv
inhibit
pkr
activ
termin
stem
directli
involv
pkr
inhibit
essenti
bind
exp
mediat
va
transport
nucleu
cytoplasm
pkr
local
sinc
silenc
suppressor
function
va
rna
intim
relat
va
rna
biogenesi
detail
descript
provid
va
rna
transcrib
rna
polymeras
iii
nucleu
infect
cell
vai
synthesi
start
earli
phase
infect
rapidli
acceler
late
phase
result
vai
molecul
accumul
high
level
moleculescel
vaii
also
synthes
high
level
late
phase
accumul
lower
concentr
vai
moleculescel
lower
express
surpris
sinc
vai
promot
stronger
vaii
promot
fact
vai
vaii
express
similar
level
va
gene
place
promot
hand
vaii
increas
concentr
vai
transcrib
suggest
transcript
competit
rna
va
rna
transcript
initi
control
two
intern
region
name
box
box
b
transcript
termin
occur
arich
region
copi
termin
utail
viral
transcript
region
highli
conserv
across
sever
serotyp
va
rna
stemloop
structur
similar
premirna
subject
similar
process
premirna
va
rna
export
cytosol
interact
fig
specif
interact
termin
stem
vai
bind
requir
va
doublestrand
stem
nucleotid
basepair
end
protrud
bind
vai
effici
fact
vai
express
plasmid
abl
bind
satur
satur
lead
inhibit
transport
cytoplasm
premirna
sirna
precursor
call
shrna
thu
rnai
block
upon
vai
express
silenc
inhibit
partial
rescu
overexpress
indic
vai
inhibit
partli
due
competit
unclear
whether
vaii
express
also
satur
whether
satur
also
occur
context
adenovir
infect
probabl
va
rna
also
block
exp
infect
cell
express
level
vai
higher
infect
transfect
cell
furthermor
silenc
also
block
adenoviralinfect
cell
addit
molecular
mechan
mediat
silenc
inhibit
presenc
va
rna
va
rna
bind
block
dicer
activ
vivo
vitro
clearli
shown
infect
cell
cell
transfect
plasmid
express
either
vai
vaii
rna
agreement
extract
obtain
cell
infect
wildtyp
adenoviru
compet
dicer
activ
vitro
wherea
normal
activ
observ
extract
cell
infect
mutant
express
va
rna
delet
vaii
alon
lead
dicerinact
extract
extract
obtain
virus
delet
vai
show
partial
dicer
activ
interestingli
dicer
activ
restor
excess
dsrna
use
reaction
data
suggest
infect
cell
vai
lesser
extent
vaii
act
rna
decoy
bind
dicer
sequest
prevent
dicer
bind
cellular
premirna
substrat
va
rna
also
induc
satur
ago
addit
mechan
block
rnai
ago
satur
may
requir
high
amount
va
rna
transfect
plasmid
express
vai
lead
inhibit
sirnamedi
silenc
indic
ago
satur
circumst
howev
extract
obtain
hour
postinfect
va
rna
detect
cytoplasm
show
reduct
risc
activ
vitro
ago
satur
due
direct
effect
va
rna
instead
ago
becom
satur
due
high
level
viralderiv
mirna
gener
dicer
process
va
rna
mention
va
rna
abl
bind
satur
dicer
dicer
rnase
capabl
process
stemloop
dsrna
shrna
premirna
sirna
mirna
respect
dicer
recogn
free
end
cut
duplex
distanc
approxim
nucleotid
therefor
unexpect
find
va
rna
process
dicer
smaller
dsrna
name
mivarna
va
rna
process
describ
vitro
also
vivo
cell
express
va
rna
transfect
adenovir
infect
vai
vaii
process
vaii
process
fragment
difficult
detect
perhap
due
lower
express
level
vaii
rna
termin
stem
va
rna
process
apic
stem
affect
effici
dicer
cleavag
mainli
determin
end
stem
length
stem
interact
loop
also
influenc
dicer
activ
va
structur
long
stem
larg
bulg
could
neg
affect
dicer
process
va
rna
fact
va
rna
process
dicer
effici
sinc
total
vai
rna
cleav
result
vai
cell
fulllength
minor
amount
process
mivarna
larger
piec
remain
dicer
process
detect
probabl
unstabl
given
molecul
vai
per
infect
cell
dicer
process
gener
molecul
mivarnascel
mivarna
abund
also
function
bind
risc
complex
inhibit
express
luciferas
report
gene
complementari
sequenc
vivo
vitro
observ
cell
transfect
plasmid
express
va
rna
adenovirusinfect
cell
mivarna
also
decreas
express
report
gene
whose
target
lack
perfect
complementar
mivarna
function
mirna
similar
adenovir
va
rna
tar
rna
also
ineffici
process
dicer
yield
viral
mirna
inhibit
express
gene
complementari
sequenc
tarderiv
mirna
target
cellular
gene
protect
infect
cell
apoptosi
infect
cell
small
rna
also
describ
contain
sequenc
nef
rev
respons
element
rre
sequenc
complementari
primer
bind
site
latter
small
rna
shown
bind
risc
control
express
report
construct
modul
hiv
replic
similar
mirna
deriv
genom
sequenc
mivarna
deciph
use
sever
technolog
primer
extens
combin
northernblot
analysi
analysi
target
cleavag
product
map
sequenc
small
rna
latter
techniqu
gener
unexpect
result
accord
sequenc
result
abund
mivarna
sequenc
deriv
end
vai
vaii
name
start
posit
process
vai
process
vaii
mivarna
also
detect
end
vai
accumul
much
lower
level
end
furthermor
mivarna
end
incorpor
risc
lower
effici
form
risc
complex
good
stabil
clone
sequenc
cytoplasm
small
rna
infect
cell
show
amount
small
rna
deriv
vaii
twice
amount
deriv
vai
sinc
amount
vaii
lower
vai
result
suggest
vaii
could
preferenti
process
dicer
clone
sequenc
bound
mirna
adenovirusinfect
cell
show
largest
proport
deriv
vaii
rna
small
rna
bound
deriv
vaii
rna
deriv
vai
suggest
vaii
mivarna
could
preferenti
bound
furthermor
rna
bound
cellular
mirna
adenovirusinfect
cell
compar
mock
infect
cell
result
suggest
probabl
cellular
ago
satur
viral
mivarna
could
explain
reduc
risc
effici
infect
cell
thu
reduct
risc
effect
due
specif
inhibit
enzymat
complex
like
due
satur
risc
mivarna
sheer
number
mivarna
would
outcompet
cellular
mirna
lead
reduct
mirna
incorpor
risc
summari
inhibit
rnai
pathway
adenovir
va
defin
result
progress
satur
critic
enzym
rnai
machineri
includ
dicer
induc
competit
displac
cellular
rnai
precursor
obviou
question
whether
synthesi
adenovir
mivarna
simpli
consequ
va
molecul
bind
rnai
pathway
enzym
caus
pathway
inhibit
satur
whether
adenoviru
could
also
exploit
rnai
pathway
gener
regulatori
mivarna
activ
import
viral
viabil
sever
result
support
second
option
describ
earlier
mivarna
function
inhibitor
express
gene
contain
complementari
sequenc
moreov
mivarnaii
found
associ
polyribosom
suggest
possibl
role
regul
gene
express
translat
level
final
specif
inhibit
mivarna
modifi
oligonucleotid
affect
viral
growth
oligonucleotid
affect
ago
satur
mirna
interact
target
result
indic
mivarna
bind
target
import
adenoviru
viabil
sever
strategi
follow
identifi
mivarna
target
bioinformat
analysi
viral
genom
reveal
potenti
target
adenoviru
genom
exclud
regul
viral
gene
express
small
rna
observ
virus
epsteinbarr
viru
herp
simplex
viru
type
fact
nucleotid
sequenc
complementari
target
bind
seed
sequenc
major
mivarna
underrepres
adenoviru
genom
suggest
viru
evolv
avoid
express
control
mivarna
identifi
potenti
cellular
target
mivarna
genom
bioinformat
studi
perform
known
mirna
induc
mrna
decay
lead
reduc
accumul
target
mrna
therefor
express
pattern
cell
express
vai
vaii
analyz
microarray
analysi
allow
identif
downregul
mrna
upregul
mrna
va
rna
express
gene
activ
includ
inflammatori
cytokin
particularli
abund
among
upregul
mrna
may
result
va
rna
activ
cytoplasm
dsrnasensor
rigi
wellknown
ifn
induc
function
analysi
downregul
gene
indic
relat
rna
metabol
fig
schemat
mivarna
biogenesi
va
rna
transcrib
viral
genom
cellular
polymeras
pol
iii
transport
cytoplasm
va
rna
bind
dicer
process
mivarna
abl
bind
ago
regul
express
target
gene
va
rna
express
high
level
satur
dicer
ago
splice
translat
encod
rnabind
protein
reason
unclear
specul
express
protein
process
bind
cellular
rna
could
detriment
adenovir
rna
va
rna
could
downregul
express
gene
encod
rna
bind
protein
unknown
mechan
order
identifi
cellular
mrna
target
mivarna
downregul
gene
scan
search
sequenc
complementari
seed
sequenc
abund
mivarna
import
notic
one
nucleotid
differ
dicer
process
yield
contain
differ
seed
sequenc
consequ
bind
differ
target
gene
downregul
express
va
rna
contain
utr
put
target
abund
mivarna
fifti
studi
detail
chosen
randomli
good
target
site
relev
gene
known
function
adequ
quantit
rtpcr
amplif
obtain
gene
mrna
level
studi
cell
express
va
rna
plasmid
transfect
differ
timepoint
viral
infect
character
gene
downregul
infect
transfect
va
rna
express
cell
number
could
scale
linearli
downregul
gene
array
mani
cellular
gene
could
target
abund
adenovir
mirna
inhibit
normal
higher
infect
cell
cell
transfect
plasmid
express
va
rna
vai
rna
could
reflect
fact
mivarna
level
infect
cell
higher
satur
risc
machineri
complex
could
effici
silenc
mivarna
target
gene
altern
mechan
relat
viral
infect
could
potenti
efficaci
risc
complex
fact
eight
gene
downregul
vaexpress
transfect
cell
cell
infect
wildtyp
adenoviru
indic
could
escap
mivarna
control
infect
gene
regul
va
rna
decreas
express
vai
rna
respond
unexpect
ago
bound
preferenti
also
sinc
overexpress
adenovir
mivarna
satur
risc
increas
level
risccontrol
gene
might
expect
howev
upregul
wellcharacter
mirna
target
may
experiment
condit
viral
mirna
product
high
enough
satur
risc
lead
product
high
level
adenovir
mirnacontrol
gene
classifi
accord
cellular
function
seven
gene
associ
cell
signal
nine
relat
cell
growth
apoptosi
nine
implic
dna
transcript
dna
repair
rbpsuh
pol
final
five
involv
rna
metabol
qki
unknown
whether
gene
direct
target
mivarna
sole
except
character
detail
shown
bind
directli
decreas
mrna
protein
express
sever
hypothes
could
explain
antivir
role
well
character
rnabind
protein
regul
express
proapoptot
molecul
rna
level
thu
adenoviru
infect
could
proceed
favour
decreas
therefor
less
apoptot
environ
furthermor
essenti
format
cytoplasm
stress
granul
associ
sever
cellular
stress
includ
viral
infect
stress
granul
would
act
mrna
hijack
induc
translat
arrest
decreas
level
would
inhibit
least
part
format
stress
granul
would
overcom
translat
arrest
may
block
viral
growth
final
bind
urich
sequenc
mrna
increas
splice
block
translat
adenovir
transcript
urich
stretch
could
allow
bind
premrna
sever
urich
sequenc
locat
region
altern
splice
fig
fact
overexpress
chang
altern
splice
lead
increas
level
aparicio
et
al
unpublish
result
thu
neg
loop
regul
may
action
earli
time
infect
level
gener
high
could
help
increas
express
would
activ
transcript
va
rna
process
mivarna
subsequ
would
downregul
lead
decreas
level
differ
altern
splice
mrna
late
time
postinfect
thu
downregul
could
contribut
shift
earli
late
phase
adenoviru
infect
similar
express
mivarna
target
gene
could
affect
adenovir
cell
cycl
fact
process
potenti
target
mivarna
apoptosi
dna
repair
inhibit
adenovirusinfect
cell
howev
evalu
adenovir
replic
cell
overexpress
sever
mivarna
target
gene
without
observ
relev
decreas
adenovir
titer
case
test
unpublish
observ
howev
exclud
sever
gene
need
control
time
posit
impact
adenovir
growth
altern
regul
mivarna
target
may
relev
natur
favour
condit
viral
growth
use
laboratori
also
mirna
regul
rapid
may
import
persist
lytic
infect
fact
associ
suggest
va
rna
express
abil
adenoviru
establish
persist
infect
given
neg
impact
va
rna
express
rna
machineri
adenovir
infect
lead
decreas
cellular
mirna
howev
mirna
express
profil
perform
cell
infect
adenoviru
type
hour
show
mirna
increas
express
mirna
show
decreas
express
compar
noninfect
control
result
contradictori
previou
observ
see
demonstr
studi
mirna
detail
upregul
hour
postadenovir
infect
prior
va
rna
accumul
decreas
hour
post
infect
probabl
due
va
rna
express
howev
extent
decreas
differ
mirna
reach
level
lower
control
cell
other
experi
requir
valid
result
adenovir
serotyp
determin
whether
higher
accumul
cellular
mirna
earli
time
postinfect
relev
viral
viabil
interestingli
downregul
late
time
adenovir
infect
also
found
downregul
cell
infect
herpesviru
saimiri
cytomegaloviru
reduc
human
papillomaviru
infect
hpv
exogen
express
markedli
inhibit
hpv
dna
synthesi
thu
could
gener
antivir
role
express
also
downregul
infect
cell
inde
also
downregul
upon
express
cancer
cell
sinc
overexpress
led
invas
metastasi
cancer
cell
one
may
specul
downregul
link
tumor
suppress
activ
adenovirus
wide
use
vector
gene
therapi
adenovirus
present
sever
advantag
use
therapeut
vector
wellestablish
method
manipul
propag
episom
locat
infect
cell
capac
accommod
larg
transgen
abil
infect
nondivid
cell
transduct
adenovir
vector
allow
effici
express
therapeut
gene
differ
organ
especi
liver
lesser
extent
lung
brain
initi
vector
socal
firstgener
adenovir
vector
lack
protein
induc
high
immun
respons
caus
part
type
ifn
activ
va
rna
therefor
firstgener
adenovir
vector
allow
shortterm
express
transgen
order
overcom
inconveni
recent
strategi
includ
use
gutless
helperdepend
hd
vector
vector
lack
viral
gene
thu
avoid
cellular
immun
respons
high
capac
accommod
transgen
element
maintain
longterm
express
genet
materi
condit
replic
adenovirus
crad
also
develop
preferenti
destroy
tumor
cell
among
crad
oncolyt
adenoviru
contain
delet
gene
lack
portion
gene
restrict
viral
growth
nontumor
cell
replicationcompet
adenovirus
also
accommod
therapeut
transgen
clever
strategi
increas
oncolyt
potenti
adenoviru
use
va
rnadelet
adenovirus
virus
select
grow
cell
inact
pkr
tumor
cell
activ
ra
epsteinbarr
viru
ebv
posit
tumor
pkr
block
express
ebv
rna
similar
va
rna
final
adenovir
vector
also
use
vaccin
adenoviralbas
vaccin
express
va
rna
may
exploit
va
activ
type
ifn
act
adjuv
boost
immun
respons
desir
antigen
function
va
rna
independ
va
rna
influenc
rnai
machineri
howev
va
rna
could
affect
rnai
machineri
express
adenovir
vector
crad
first
gener
adenovir
vector
contain
va
gene
state
previous
va
rna
express
satur
rnai
machineri
lead
loss
regul
exert
cellular
mirna
toxic
consequ
transduc
cell
satur
effect
even
promin
vector
overexpress
shrna
transgen
fact
overexpress
shrna
adenoassoci
viral
vector
lead
lethal
mice
satur
cellular
rnai
machineri
howev
shrna
deliv
firstgener
adenovir
vector
effici
downregul
express
target
gene
mice
without
detect
impact
accumul
function
cellular
mirna
lack
toxic
case
could
explain
two
reason
first
cellular
mirna
stabl
longterm
satur
silenc
machineri
overexpress
shrna
va
rna
could
disrupt
mirnamedi
regul
howev
first
gener
adenovir
vector
express
transgen
shortterm
second
firstgener
adenovir
vector
va
rna
level
reach
satur
level
sinc
vector
lack
increas
transcript
va
rna
allow
replic
viral
genom
provid
new
dna
copi
va
rna
express
even
va
rna
express
adenovir
vector
appear
interfer
process
function
therapeut
shrna
remov
va
gene
would
elimin
possibl
sequest
rnai
machineri
might
increas
shrna
potenc
elimin
va
sequenc
togeth
viral
gene
result
hd
vector
abl
express
transgen
long
period
time
one
exampl
shrna
express
hd
vector
satur
rnai
pathway
caus
activ
interferon
respons
may
interest
adjuv
treatment
viral
infect
hepat
b
hepat
c
viru
hbv
hcv
exampl
hd
vector
express
function
shrna
without
detect
unwant
secondari
effect
target
type
collagen
cartilag
format
type
diabet
hbv
huntingtin
huntington
diseas
sever
oncolyt
vector
express
shrna
also
success
silenc
oncogen
gene
kra
angiogen
factor
vegf
antiapoptot
gene
apollon
survivin
xiap
prolifer
induc
telomeras
htert
unfortun
report
inform
function
rnai
machineri
cell
infect
vector
interestingli
rnai
pathway
use
modul
viral
tropism
oncolyt
vector
oncolyt
adenoviru
design
express
mirna
target
adenovir
gene
vector
transduc
tumor
viru
could
replic
exert
oncolyt
abil
oncolyt
adenovirus
may
toxic
sinc
also
reach
healthi
tissu
especi
liver
howev
modifi
oncolyt
adenoviru
express
liver
organ
activ
product
mirna
target
adenovir
gene
therefor
suppress
viral
replic
infect
thu
vector
turn
liversaf
oncolyt
viru
second
approach
modul
viral
tropism
decreas
toxic
oncolyt
vector
exploit
regul
cellular
mirna
oncolyt
virus
construct
bind
site
liver
high
level
express
adenovir
replic
abrog
howev
oncolyt
potenti
retain
tumor
cell
summari
mirnaspecif
control
wild
type
viru
provid
new
attract
strategi
design
safer
gene
therapi
vector
begin
understand
better
exploit
relationship
adenovir
infect
rnai
machineri
adenovirus
evolv
simultan
use
block
process
express
process
high
amount
va
rna
mivarna
may
lead
satur
pathway
therefor
block
cellular
mirna
control
time
key
enzym
rnai
machineri
load
noncod
viral
rna
effici
control
express
viral
mirna
target
gene
main
question
still
address
benefit
viru
delic
equilibrium
sever
author
shown
silenc
machineri
may
antivir
role
theoret
replic
intermedi
rna
virus
abund
secondari
structur
viral
rna
could
cleav
dicer
gener
antivir
mirna
fact
block
dicer
function
silenc
suppressor
specif
shrna
result
increas
adenovir
titer
carnero
et
al
unpublish
result
howev
antivir
role
rnai
clearli
demonstr
anim
virus
dicer
process
viral
sequenc
gener
antivir
mirna
never
shown
viralinfect
anim
cell
futur
experi
also
address
function
relev
mivarna
viabil
studi
adenovir
version
produc
function
va
rna
process
mivarna
mutat
seed
sequenc
viral
viabil
also
studi
cell
overexpress
downregul
mivarna
target
gene
differ
environ
anim
model
could
use
perform
experi
recent
shown
syrian
hamster
partial
permiss
adenovir
replic
imped
murin
cell
final
special
attent
paid
put
role
cellular
mirna
viral
infect
taken
togeth
approach
lead
identif
valid
protein
mirna
antiadenovir
properti
may
also
relev
virus
therapeut
interest
moreov
studi
allow
develop
recombin
adenovirus
increas
efficaci
gene
therapi
applic
